30 results
8-K
EX-3.2
SGTX
Sigilon Therapeutics Inc
11 Aug 23
Completion of Acquisition or Disposition of Assets
4:16pm
be assigned by the Board of Directors.
Section 6. Treasurer. The Treasurer (if any) shall in general have all duties incident to the position … incident to the office of Secretary and such other duties as may be assigned by the Board of Directors.
Section 8. Other Officers. Such other officers
10-K
2020 FY
EX-10.5
SGTX
Sigilon Therapeutics Inc
18 Mar 21
Annual report
4:31pm
rights of recovery against the other for direct or consequential loss or damage arising out of or incident to the perils covered by property … for direct or consequential loss or damage arising out of or incident to the perils covered by property insurance carried or required be carried
S-1
EX-3.3
SGTX
Sigilon Therapeutics Inc
13 Nov 20
IPO registration
3:27pm
subject to the direction of the Board of Directors, and shall perform all duties and have all powers that are commonly incident to the office … , the Secretary shall perform such duties and have such powers as are incident to the office of the secretary, including without limitation the duty
DRS/A
EX-3.3
SGTX
Sigilon Therapeutics Inc
30 Oct 20
Draft registration statement (amended)
12:00am
subject to the direction of the Board of Directors, and shall perform all duties and have all powers that are commonly incident to the office … , the Secretary shall perform such duties and have such powers as are incident to the office of the secretary, including without limitation the duty
S-1/A
EX-1.1
SGTX
Sigilon Therapeutics Inc
30 Nov 20
IPO registration (amended)
6:41am
incident to the performance of their obligations under this Agreement, including: (i) the fees, disbursements and expenses of the Company’s counsel … in connection with the preparation and filing of the registration statement on Form 8-A relating to the Common Stock and all costs and expenses incident
SC 14D9
EX-99
yhklqbt5jgu1 w982p
13 Jul 23
Tender offer solicitation
8:18am
S-1/A
EX-3.5
53iz7zlb487vn gwjbp1
30 Nov 20
IPO registration (amended)
6:41am
8-K
EX-3.2
rqepx
8 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:05pm
8-K
EX-2.1
usekau3tj2x65l
29 Jun 23
Lilly to Acquire Sigilon Therapeutics
7:03am
S-3
EX-1.2
lygqaf2x2uztkfdwkl4a
14 Apr 22
Shelf registration
4:34pm
S-1
EX-10.2
argt9t01suliocoq0g4
13 Nov 20
IPO registration
3:27pm
DRS/A
EX-10.14
um9rlt0ete7jfwinxu0o
30 Oct 20
Draft registration statement (amended)
12:00am
S-1
EX-10.1
nga7dgl2mg91kwnv8v76
13 Nov 20
IPO registration
3:27pm
DRS
EX-10.1
kq5d7wesi
21 Aug 20
Draft registration statement
12:00am